Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Sulphonamides industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Pfizer
Roche Holding AG
Novartis International AG
GlaxoSmithKline
Mylan Pharmaceuticals
Bayer AG
Stiefel Laboratories
Boehringer Ingelheim Pharmaceuticals
Par Pharmaceutical
King Pharmaceuticals
By Type:
Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Orally Absorbable Sulfonamide
By Application:
Gastro Intestinal Tract (GIT) Infection
Skin Infections
Meningitis
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Sulphonamides Market Overview 2018-2029
-
1.1 China Sulphonamides Industry Development Overview
-
1.2 China Sulphonamides Industry Development History
-
1.3 China Sulphonamides Industry Market Size (2018-2029)
-
1.4 China Sulphonamides Market Analysis by Type from Production Side
-
1.4.1 China Sulphonamides Production Volume, Production Value and Growth Rate of Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) (2018-2029)
-
1.4.2 China Sulphonamides Production Volume, Production Value and Growth Rate of Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) (2018-2029)
-
1.4.3 China Sulphonamides Production Volume, Production Value and Growth Rate of Orally Absorbable Sulfonamide (2018-2029)
-
1.5 China Sulphonamides Market Analysis by Application from Consumption End
-
1.5.1 China Sulphonamides Sales Volume, Sales Value and Growth Rate of Gastro Intestinal Tract (GIT) Infection (2018-2029)
-
1.5.2 China Sulphonamides Sales Volume, Sales Value and Growth Rate of Skin Infections (2018-2029)
-
1.5.3 China Sulphonamides Sales Volume, Sales Value and Growth Rate of Meningitis (2018-2029)
-
1.6 China Sulphonamides Market Analysis by Region
-
1.6.1 North China Sulphonamides Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Sulphonamides Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Sulphonamides Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Sulphonamides Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Sulphonamides Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Sulphonamides Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Sulphonamides Market Size and Growth Rate from 2018-2029
Chapter 2 China Sulphonamides Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Sulphonamides Market Status and Competition at home and abroad in 2023
-
2.2.2 China Sulphonamides Market Status and Competition Analysis in 2023
-
2.2.3 China Sulphonamides Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Sulphonamides Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Sulphonamides Industry Development
Chapter 3 SulphonamidesIndustry Chain Analysis
-
3.1 Sulphonamides Industry Chain
-
3.2 Sulphonamides Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Sulphonamides Market
-
3.3 Sulphonamides Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Sulphonamides Market
Chapter 4 China Sulphonamides Market, by Type
-
4.1 China Sulphonamides Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Sulphonamides Total Production Volume and Growth Rate from Production Side
-
4.5 China Sulphonamides Production Volume and Growth Rate, by Type
-
4.5.1 China Sulphonamides Production Volume and Growth Rate of Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
-
4.5.2 China Sulphonamides Production Volume and Growth Rate of Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
-
4.5.3 China Sulphonamides Production Volume and Growth Rate of Orally Absorbable Sulfonamide
Chapter 5 China Sulphonamides Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Sulphonamides Total Market Size and Growth Rate from Consumption End
-
5.5 China Sulphonamides Market Size and Growth Rate, by Application
-
5.5.1 China Sulphonamides Market Size and Growth Rate of Gastro Intestinal Tract (GIT) Infection
-
5.5.2 China Sulphonamides Market Size and Growth Rate of Skin Infections
-
5.5.3 China Sulphonamides Market Size and Growth Rate of Meningitis
Chapter 6 China Sulphonamides Market, by Region
-
6.1 China Sulphonamides Production Volume and Production Value, by Region
-
6.2 China Sulphonamides Sales Volume and Sales Value, by Region
Chapter 7 North China Sulphonamides Market Analysis
-
7.1 North China Sulphonamides Market, by Type
-
7.2 North China Sulphonamides Market, by Application
Chapter 8 Central China Sulphonamides Market Analysis
-
8.1 Central China Sulphonamides Market, by Type
-
8.2 Central China Sulphonamides Market, by Application
Chapter 9 South China Sulphonamides Market Analysis
-
9.1 South China Sulphonamides Market, by Type
-
9.2 South China Sulphonamides Market, by Application
Chapter 10 East China Sulphonamides Market Analysis
-
10.1 East China Sulphonamides Market, by Type
-
10.2 East China Sulphonamides Market, by Application
Chapter 11 Northeast China Sulphonamides Market Analysis
-
11.1 Northeast China Sulphonamides Market, by Type
-
11.2 Northeast China Sulphonamides Market, by Application
Chapter 12 Southwest China Sulphonamides Market Analysis
-
12.1 Southwest China Sulphonamides Market, by Type
-
12.2 Southwest China Sulphonamides Market, by Application
Chapter 13 Northwest China Sulphonamides Market Analysis
-
13.1 Northwest China Sulphonamides Market, by Type
-
13.2 Northwest China Sulphonamides Market, by Application
Chapter 14 Company Profiles
-
14.1 Pfizer
-
14.1.1 Pfizer Company Profile
-
14.1.2 Pfizer Sulphonamides Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Roche Holding AG
-
14.2.1 Roche Holding AG Company Profile
-
14.2.2 Roche Holding AG Sulphonamides Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Novartis International AG
-
14.3.1 Novartis International AG Company Profile
-
14.3.2 Novartis International AG Sulphonamides Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Profile
-
14.4.2 GlaxoSmithKline Sulphonamides Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Mylan Pharmaceuticals
-
14.5.1 Mylan Pharmaceuticals Company Profile
-
14.5.2 Mylan Pharmaceuticals Sulphonamides Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Bayer AG
-
14.6.1 Bayer AG Company Profile
-
14.6.2 Bayer AG Sulphonamides Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Stiefel Laboratories
-
14.7.1 Stiefel Laboratories Company Profile
-
14.7.2 Stiefel Laboratories Sulphonamides Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Boehringer Ingelheim Pharmaceuticals
-
14.8.1 Boehringer Ingelheim Pharmaceuticals Company Profile
-
14.8.2 Boehringer Ingelheim Pharmaceuticals Sulphonamides Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Par Pharmaceutical
-
14.9.1 Par Pharmaceutical Company Profile
-
14.9.2 Par Pharmaceutical Sulphonamides Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 King Pharmaceuticals
-
14.10.1 King Pharmaceuticals Company Profile
-
14.10.2 King Pharmaceuticals Sulphonamides Market Performance
-
14.10.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Sulphonamides Industry Research Conclusions
-
15.2 Sulphonamides Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Sulphonamides Industry Market Size (2018-2029)
-
Figure China Sulphonamides Production Volume, Production Value and Growth Rate of Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) (2018-2029)
-
Figure China Sulphonamides Production Volume, Production Value and Growth Rate of Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) (2018-2029)
-
Figure China Sulphonamides Production Volume, Production Value and Growth Rate of Orally Absorbable Sulfonamide (2018-2029)
-
Figure China Sulphonamides Sales Volume, Sales Value and Growth Rate of Gastro Intestinal Tract (GIT) Infection (2018-2029)
-
Figure China Sulphonamides Sales Volume, Sales Value and Growth Rate of Skin Infections (2018-2029)
-
Figure China Sulphonamides Sales Volume, Sales Value and Growth Rate of Meningitis (2018-2029)
-
Figure North China Sulphonamides Market Size and Growth Rate from 2018-2029
-
Figure Central China Sulphonamides Market Size and Growth Rate from 2018-2029
-
Figure South China Sulphonamides Market Size and Growth Rate from 2018-2029
-
Figure East China Sulphonamides Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Sulphonamides Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Sulphonamides Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Sulphonamides Market Size and Growth Rate from 2018-2029
-
Figure Sulphonamides Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Sulphonamides Market Share by Type in 2018
-
Figure China Sulphonamides Market Share by Type in 2023
-
Figure China Sulphonamides Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Sulphonamides Production Volume and Growth Rate of Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) (2018-2023)
-
Figure China Sulphonamides Production Volume and Growth Rate of Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) (2018-2023)
-
Figure China Sulphonamides Production Volume and Growth Rate of Orally Absorbable Sulfonamide (2018-2023)
-
Figure China Sulphonamides Market Share by Application in 2018
-
Figure China Sulphonamides Market Share by Application in 2023
-
Figure China Sulphonamides Total Market Size and Growth Rate from Consumption End
-
Figure China Sulphonamides Market Size and Growth Rate of Gastro Intestinal Tract (GIT) Infection (2018-2023)
-
Figure China Sulphonamides Market Size and Growth Rate of Skin Infections (2018-2023)
-
Figure China Sulphonamides Market Size and Growth Rate of Meningitis (2018-2023)
-
Table China Sulphonamides Production Volume by Region (2018-2023)
-
Table China Sulphonamides Production Volume Share by Region (2018-2023)
-
Figure China Sulphonamides Production Volume Share by Region (2018-2023)
-
Table China Sulphonamides Production Value by Region (2018-2023)
-
Table China Sulphonamides Production Value Share by Region (2018-2023)
-
Figure China Sulphonamides Production Value Share by Region (2018-2023)
-
Table China Sulphonamides Sales Volume by Region (2018-2023)
-
Table China Sulphonamides Sales Volume Share by Region (2018-2023)
-
Figure China Sulphonamides Sales Volume Share by Region (2018-2023)
-
Table China Sulphonamides Sales Value by Region (2018-2023)
-
Table China Sulphonamides Sales Value Share by Region (2018-2023)
-
Figure China Sulphonamides Sales Value Share by Region (2018-2023)
-
Table North China Sulphonamides Production Volume by Type (2018-2023)
-
Table North China Sulphonamides Production Volume Share by Type (2018-2023)
-
Figure North China Sulphonamides Production Volume Share by Type (2018-2023)
-
Table North China Sulphonamides Sales Volume by Application (2018-2023)
-
Table North China Sulphonamides Sales Volume Share by Application (2018-2023)
-
Figure North China Sulphonamides Sales Volume Share by Application (2018-2023)
-
Table Central China Sulphonamides Production Volume by Type (2018-2023)
-
Table Central China Sulphonamides Production Volume Share by Type (2018-2023)
-
Figure Central China Sulphonamides Production Volume Share by Type (2018-2023)
-
Table Central China Sulphonamides Sales Volume by Application (2018-2023)
-
Table Central China Sulphonamides Sales Volume Share by Application (2018-2023)
-
Figure Central China Sulphonamides Sales Volume Share by Application (2018-2023)
-
Table South China Sulphonamides Production Volume by Type (2018-2023)
-
Table South China Sulphonamides Production Volume Share by Type (2018-2023)
-
Figure South China Sulphonamides Production Volume Share by Type (2018-2023)
-
Table South China Sulphonamides Sales Volume by Application (2018-2023)
-
Table South China Sulphonamides Sales Volume Share by Application (2018-2023)
-
Figure South China Sulphonamides Sales Volume Share by Application (2018-2023)
-
Table East China Sulphonamides Production Volume by Type (2018-2023)
-
Table East China Sulphonamides Production Volume Share by Type (2018-2023)
-
Figure East China Sulphonamides Production Volume Share by Type (2018-2023)
-
Table East China Sulphonamides Sales Volume by Application (2018-2023)
-
Table East China Sulphonamides Sales Volume Share by Application (2018-2023)
-
Figure East China Sulphonamides Sales Volume Share by Application (2018-2023)
-
Table Northeast China Sulphonamides Production Volume by Type (2018-2023)
-
Table Northeast China Sulphonamides Production Volume Share by Type (2018-2023)
-
Figure Northeast China Sulphonamides Production Volume Share by Type (2018-2023)
-
Table Northeast China Sulphonamides Sales Volume by Application (2018-2023)
-
Table Northeast China Sulphonamides Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Sulphonamides Sales Volume Share by Application (2018-2023)
-
Table Southwest China Sulphonamides Production Volume by Type (2018-2023)
-
Table Southwest China Sulphonamides Production Volume Share by Type (2018-2023)
-
Figure Southwest China Sulphonamides Production Volume Share by Type (2018-2023)
-
Table Southwest China Sulphonamides Sales Volume by Application (2018-2023)
-
Table Southwest China Sulphonamides Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Sulphonamides Sales Volume Share by Application (2018-2023)
-
Table Northwest China Sulphonamides Production Volume by Type (2018-2023)
-
Table Northwest China Sulphonamides Production Volume Share by Type (2018-2023)
-
Figure Northwest China Sulphonamides Production Volume Share by Type (2018-2023)
-
Table Northwest China Sulphonamides Sales Volume by Application (2018-2023)
-
Table Northwest China Sulphonamides Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Sulphonamides Sales Volume Share by Application (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Sulphonamides Revenue, Price and Gross (2018-2023)
-
Table Roche Holding AG Company Profile
-
Table Roche Holding AG Sulphonamides Revenue, Price and Gross (2018-2023)
-
Table Novartis International AG Company Profile
-
Table Novartis International AG Sulphonamides Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Company Profile
-
Table GlaxoSmithKline Sulphonamides Revenue, Price and Gross (2018-2023)
-
Table Mylan Pharmaceuticals Company Profile
-
Table Mylan Pharmaceuticals Sulphonamides Revenue, Price and Gross (2018-2023)
-
Table Bayer AG Company Profile
-
Table Bayer AG Sulphonamides Revenue, Price and Gross (2018-2023)
-
Table Stiefel Laboratories Company Profile
-
Table Stiefel Laboratories Sulphonamides Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim Pharmaceuticals Company Profile
-
Table Boehringer Ingelheim Pharmaceuticals Sulphonamides Revenue, Price and Gross (2018-2023)
-
Table Par Pharmaceutical Company Profile
-
Table Par Pharmaceutical Sulphonamides Revenue, Price and Gross (2018-2023)
-
Table King Pharmaceuticals Company Profile
-
Table King Pharmaceuticals Sulphonamides Revenue, Price and Gross (2018-2023)
-
